Hanmi Pharm. Co., Ltd. (KRX:128940)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Reconciliation of Inter-Sector Transactions			-114.82B	-101.69B	-89.72B	-89.38B	-114.75B
Overseas Medicine			397.69B	350.64B	288.73B	203.53B	254.41B
Overseas Medicine Growth			13.42%	21.44%	41.86%	-20.00%	11.48%
Medicine			1.10T	982.05B	917.02B	872.40B	863.65B
Medicine Growth			11.70%	7.09%	5.11%	1.01%	8.63%
Raw Drug Substance			111.07B	100.55B	87.16B	89.29B	110.34B
Raw Drug Substance Growth			10.46%	15.36%	-2.39%	-19.07%	29.34%
Total			1.49T	1.33T	1.20T	1.08T	1.11T
Total Growth			11.97%	10.67%	11.84%	-3.39%	9.62%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Republic of Korea			890.76B	826.08B	768.94B	705.97B	678.52B
Republic of Korea Growth			7.83%	7.43%	8.92%	4.05%	13.33%
Other			75.48B	63.69B	44.14B	51.97B	63.92B
Other Growth			18.51%	44.29%	-15.07%	-18.69%	-14.47%
China			404.85B	356.11B	321.56B	220.71B	275.54B
China Growth			13.69%	10.75%	45.69%	-19.90%	13.96%
Japan			51.81B	44.80B	41.13B	52.18B	56.90B
Japan Growth			15.65%	8.93%	-21.18%	-8.29%	115.20%
The United States of America			67.99B	40.87B	27.43B	45.03B	38.78B
The United States of America Growth			66.36%	49.00%	-39.09%	16.11%	-47.79%
Total			1.49T	1.33T	1.20T	1.08T	1.11T
Total Growth			11.97%	10.67%	11.84%	-3.39%	9.62%

Source: S&P Global Market Intelligence.